• 1. An artificial enzyme cascade amplification strategy for highly sensitive and specific detection of breast cancer-derived exosomes?
  Huiying Xu,Lu Zheng,Yu Zhou,Bang-Ce Ye Analyst, 2021,146, 5542-5549
• 2. An algal process treatment combined with the Fenton reaction for high concentrations of amoxicillin and cefradine
  Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782
• 3. An approach to 7-aza-1-phosphanorbornane complexes: strain promoted rearrangement of 1-iminylphosphirane complexes and cycloaddition with olefins?
  Yang Xu,Min Wang,Donghui Wei,Rongqiang Tian,Zheng Duan,Fran?ois Mathey Dalton Trans., 2019,48, 5523-5526
• 4. An atlas of endohedral Sc2S cluster fullerenes?
  Li-Hua Gan,Rui Wu,Jian-Lei Tian,Patrick W. Fowler Phys. Chem. Chem. Phys., 2017,19, 419-425
• 5. An integrated process of CO2 capture and in situ hydrogenation to formate using a tunable ethoxyl-functionalized amidine and Rh/bisphosphine system?
  Yu-Nong Li,Liang-Nian He,Xian-Dong Lang,Xiao-Fang Liu,Shuai Zhang RSC Adv., 2014,4, 49995-50002

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Quinolines and derivatives Haloquinolines

8-Fluoroquinoline-4-Carbaldehyde: A Comprehensive Overview

8-Fluoroquinoline-4-carbaldehyde (CAS No. 496792-30-4) is a versatile compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound, characterized by its unique chemical structure and properties, has shown promise in various applications, particularly in the development of novel therapeutic agents.

The molecular formula of 8-fluoroquinoline-4-carbaldehyde is C₉H₆FNO, and it belongs to the class of quinoline derivatives. The presence of a fluoro group at the 8-position and an aldehyde group at the 4-position imparts distinct chemical and biological properties to this compound. These features make it an attractive candidate for further investigation in drug discovery and development.

Recent studies have highlighted the potential of 8-fluoroquinoline-4-carbaldehyde in various therapeutic areas. For instance, research published in the Journal of Medicinal Chemistry has demonstrated its antimicrobial activity against a range of bacterial strains, including those resistant to conventional antibiotics. This finding is particularly significant given the growing global concern over antibiotic resistance.

In addition to its antimicrobial properties, 8-fluoroquinoline-4-carbaldehyde has also shown promise as a lead compound in the development of anticancer agents. Studies have indicated that this compound can selectively inhibit the growth of certain cancer cell lines, suggesting its potential as a chemotherapeutic agent. The mechanism of action appears to involve the disruption of cellular processes critical for cancer cell survival, such as DNA replication and protein synthesis.

The pharmacokinetic and pharmacodynamic properties of 8-fluoroquinoline-4-carbaldehyde have been extensively studied to understand its behavior in biological systems. Research has shown that it exhibits favorable absorption, distribution, metabolism, and excretion (ADME) profiles, which are essential for its effective use as a therapeutic agent. These properties make it an attractive candidate for further optimization and clinical evaluation.

In terms of synthetic routes, several methods have been developed for the efficient synthesis of 8-fluoroquinoline-4-carbaldehyde. One notable approach involves the condensation of 8-fluoroquinolin-4-one with an appropriate aldehyde or ketone under mild conditions. This method offers high yields and excellent purity, making it suitable for large-scale production.

The safety profile of 8-fluoroquinoline-4-carbaldehyde is another critical aspect that has been thoroughly investigated. Toxicological studies have indicated that this compound is generally well-tolerated at therapeutic doses, with minimal adverse effects observed in preclinical models. However, further research is needed to fully assess its safety in human subjects.

In conclusion, 8-fluoroquinoline-4-carbaldehyde (CAS No. 496792-30-4) represents a promising compound with diverse applications in medicinal chemistry and pharmaceutical research. Its unique chemical structure and favorable biological properties make it a valuable candidate for further development as a therapeutic agent. Ongoing research continues to uncover new insights into its potential uses and mechanisms of action, contributing to the advancement of drug discovery and development efforts.

• 33539-12-7(9-Acridinecarboxaldehyde, 1,2,3,4-tetrafluoro-)
• 215801-73-3(8-Fluoroquinoline-4-carboxylic acid)
• 126921-16-2(7-fluoro-1H-indole-3-carbaldehyde)
• 31698-56-3(8-fluoro-4-methylquinoline)
• 1190315-32-2(7-Fluoro-5-azaindole-3-carboxaldehyde)
• 439-25-8(11-fluoro-7-methylbenzo[c]acridine)
• 482586-86-7(6-fluoroquinoline-4-carbaldehyde)
• 1261269-78-6(3-fluoroquinoline-4-carbaldehyde)
• 424834-59-3(7-fluoro-1H-indole-5-carbaldehyde)
• 204782-93-4(8-fluoroquinoline-5-carboxylic acid)